Australia’s non-invasive prenatal testing market is set to soar between 2018 and 2024, fueled by groundbreaking technological advancements and a rising demand for early genetic screening. This exciting evolution in the healthcare sector promises to transform how expectant parents approach prenatal care, as highlighted by GlobeNewswire.
SNBL and Tasso, Inc. have announced a strategic joint venture in Japan aimed at advancing innovative healthcare solutions. This collaboration is set to enhance patient accessibility to advanced diagnostic tools in the region, strengthening both companies’ market presence.
bioMérieux has announced that it has received Health Canada approval for its BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel. This diagnostic tool aims to enhance rapid testing for respiratory infections, providing efficient solutions for patient care in Canada.
